Event

Genotoxic Impurities in Pharmaceuticals Summit 2024

Oct 07 - 10, 2024

Prague, Czech Republic

The Genotoxic Impurities in Pharmaceuticals Summit 2024 is a critical event for pharmaceutical professionals focusing on the identification, risk assessment, and control of genotoxic impurities in drug development. Attendees will gain insights into the latest regulatory guidelines, explore advanced analytical methods, and learn best practices for managing genotoxic impurities. This summit offers a unique platform to connect with global experts, participate in discussions on current challenges, and discover innovative solutions for ensuring the safety and compliance of pharmaceutical products. Join us to stay informed on the evolving landscape of genotoxic impurity management.

12 Grids12 Grids

Stay ahead in the Pharma game

Register for this event now!

Speaker line up

Andrew Teasdale

Andrew Teasdale

Astrazeneca

Sr. Principal Scientist

Lance Smallshaw

Lance Smallshaw

UCB

Global Analytical / Quality Expert, Head of Compendial Affairs

Raphael Nudelman

Raphael Nudelman

Teva Pharmaceuticals

Former Impurity Expert

About the Organiser

Qepler Events Group

Prague, Czech Republic

Qepler is a progressive supplier of B2B summits and conferences. We produce events custom-made to provide each client with the utmost professional training.

Frequently Asked Questions
What is the Genotoxic Impurities in Pharmaceuticals Summit 2024 about?
This summit focuses on addressing the latest challenges, regulations, and methodologies related to the identification, control, and management of genotoxic impurities (GTIs) in pharmaceutical products.
What key topics will be covered?
The summit will explore topics such as regulatory updates (ICH M7 guidelines), analytical techniques for detecting GTIs, risk assessment, toxicological evaluation, and strategies to mitigate genotoxic impurities during drug development.
Who should attend this summit?
The event is ideal for professionals in pharmaceutical R&D, regulatory affairs, quality control, toxicology, and risk assessment, especially those involved in managing impurities in drug development and production.

Day and Timing

Monday, Oct 7 - 10

Location

Prague, Czech Republic

Entry Fees

Paid

Frequency

Annually

Event Type

Event

Duration

4 Days

Website

qepler.com
Ad
Advertisement
News Letter

Subscribe to our Newsletter!

Be the first to get exclusive offers and the latest news

Stay ahead in the Pharma game

Register for this event now!

Day and Timing

Monday, Oct 7 - 10

Location

Prague, Czech Republic

Entry Fees

Paid

Frequency

Annually

Event Type

Event

Duration

4 Days

Website

qepler.com

Speaker line up

Andrew Teasdale

Andrew Teasdale

Astrazeneca

Sr. Principal Scientist

Lance Smallshaw

Lance Smallshaw

UCB

Global Analytical / Quality Expert, Head of Compendial Affairs

Raphael Nudelman

Raphael Nudelman

Teva Pharmaceuticals

Former Impurity Expert

About the Organiser

Qepler Events Group

Prague, Czech Republic

Qepler is a progressive supplier of B2B summits and conferences. We produce events custom-made to provide each client with the utmost professional training.

Ad
Advertisement
Frequently Asked Questions
What is the Genotoxic Impurities in Pharmaceuticals Summit 2024 about?
This summit focuses on addressing the latest challenges, regulations, and methodologies related to the identification, control, and management of genotoxic impurities (GTIs) in pharmaceutical products.
What key topics will be covered?
The summit will explore topics such as regulatory updates (ICH M7 guidelines), analytical techniques for detecting GTIs, risk assessment, toxicological evaluation, and strategies to mitigate genotoxic impurities during drug development.
Who should attend this summit?
The event is ideal for professionals in pharmaceutical R&D, regulatory affairs, quality control, toxicology, and risk assessment, especially those involved in managing impurities in drug development and production.
News Letter

Subscribe to our Newsletter!

Be the first to get exclusive offers and the latest news